1. Home
  2. CHRW vs ILMN Comparison

CHRW vs ILMN Comparison

Compare CHRW & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C.H. Robinson Worldwide Inc.

CHRW

C.H. Robinson Worldwide Inc.

HOLD

Current Price

$167.79

Market Cap

23.0B

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$124.65

Market Cap

19.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHRW
ILMN
Founded
1905
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.0B
19.0B
IPO Year
1997
2000

Fundamental Metrics

Financial Performance
Metric
CHRW
ILMN
Price
$167.79
$124.65
Analyst Decision
Buy
Hold
Analyst Count
20
17
Target Price
$174.53
$124.24
AVG Volume (30 Days)
1.5M
1.5M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
1.49%
N/A
EPS Growth
25.13
170.87
EPS
4.83
5.45
Revenue
$14,869,380,000.00
$4,343,000,000.00
Revenue This Year
$4.33
$6.54
Revenue Next Year
$6.54
$5.49
P/E Ratio
$35.18
$23.16
Revenue Growth
N/A
N/A
52 Week Low
$84.68
$68.70
52 Week High
$203.34
$155.53

Technical Indicators

Market Signals
Indicator
CHRW
ILMN
Relative Strength Index (RSI) 40.47 49.06
Support Level $148.27 $124.27
Resistance Level $167.90 $126.00
Average True Range (ATR) 5.23 4.43
MACD -0.67 0.75
Stochastic Oscillator 11.46 68.47

Price Performance

Historical Comparison
CHRW
ILMN

About CHRW C.H. Robinson Worldwide Inc.

C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (about 60% of net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm operates a large air and ocean forwarding division (30%), which has grown organically and via tuck-in acquisitions over the years. The remainder of revenue consists of transportation management services and a legacy produce-sourcing operation.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: